Getting Started
← Back to all articles

When Side Effects Get Bad, Do You Talk to a Human or a Chatbot?

Who do I talk to when side effects get bad — a human or a chatbot?

What to expect when you message your care team about a GLP-1 side effect, and what questions to ask a provider before you start treatment to find out who actually answers.

Published September 2, 2026

Key takeaways

  • Mazrek patients have unlimited messaging with their care team through the patient portal — dose adjustments and side effect management go to a licensed provider, not a support bot.
  • Prescribing decisions and dose changes are made by licensed providers at Arora Health, an independent medical group — not by an algorithm.
  • Before starting treatment anywhere, it's reasonable to ask directly: who reviews messages, and is a licensed provider available for dose changes?
  • For anything that could be an emergency, don't wait on a message thread — call 911 or go to an ER.

Mazrek

Physician-reviewed GLP-1 care

  • State-licensed compounding pharmacy partner
  • Certificate of analysis provided per batch
  • Every prescription reviewed by a licensed provider
  • Unlimited care team messaging
Start your intake →

Prescription required. Treatment is only provided if clinically appropriate, as determined by a licensed provider.

Why this question matters more than it sounds

GLP-1 side effects are common enough that they're expected, not exceptional — nausea, constipation, fatigue, and appetite changes show up for a real share of patients, especially during dose titration. The question isn't whether you'll ever need to reach out, it's what happens when you do: does a licensed clinician see your message, or does a chatbot triage it and hope it resolves itself?

Some platforms are structured so that "support" is a ticketing system or a scripted bot, with actual clinical review reserved for the initial intake and largely absent afterward. That's a meaningful gap, because dose titration is exactly when problems tend to surface.

How it works with Mazrek

Every Mazrek patient has unlimited messaging with their care team through the patient portal. Prescribing decisions, dose adjustments, and side effect management are handled by licensed providers at Arora Health — Mazrek's medical group — not by a support bot or an automated flow. If your dose needs to change because of how you're responding, that's a clinical call made by the person who's actually reviewing your case, not a rule fired off a form response.

Questions worth asking before you start treatment anywhere

  1. Who reads a message when I report a side effect — is it a licensed clinician?
  2. Is there a limit on how often I can message, or an extra fee for follow-up review?
  3. If my dose needs to change, who makes that call, and how fast?
  4. What's the process for something urgent versus something that can wait a day?

If a provider can't answer these clearly before you've paid anything, that's worth weighing before you commit.

Frequently asked

What counts as a side effect worth messaging your provider about?+

Persistent nausea or vomiting that keeps you from eating or drinking, signs of dehydration, severe abdominal pain, or any symptom that feels different from the mild, expected GI adjustment period. When in doubt, message — that's what the care team is for.

What should I do for a symptom that could be an emergency?+

Call 911 or go to an emergency room. Messaging a care team is for ongoing management and dose adjustments, not for acute emergencies like severe allergic reaction or symptoms of pancreatitis.

Mazrek

Physician-guided care for weight, longevity, and cellular health. 18+, U.S. residents only.

Medication is prepared by VialsRx, a licensed U.S. pharmacy. Prescribed by independent licensed providers through Arora Health.

This website does not provide medical advice. Prescription products require an online consultation with a licensed provider who determines whether treatment is appropriate. Not everyone is eligible. Do not use GLP-1 medications if you have a personal or family history of medullary thyroid carcinoma (MTC) or MEN2. Compounded medications are not reviewed or approved by the FDA. Results vary and are not guaranteed. © 2026 Mazrek Health. All rights reserved.